FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer
FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer Mega Doctor News
Онкология
Колоректальный рак
142 материалов по теме, собраны автоматически из проверенных источников
Онкология
Vijay Shah: FDA Approves Atezolizumab for Stage III dMMR Colon Cancer
Vijay Shah: FDA Approves Atezolizumab for Stage III dMMR Colon Cancer Oncodaily
:focal(0.5:0.42):og(360tv.ru,%27%D0%90%D0%BD%D0%B0%D0%BB%D0%B8%D0%B7%20%D0%BD%D0%B0%20%D1%81%D0%BA%D1%80%D1%8B%D1%82%D1%83%D1%8E%20%D0%BA%D1%80%D0%BE%D0%B2%D1%8C%20%D0%BF%D0%BE%D0%BC%D0%BE%D0%B3%20%D0%B2%D0%BE%D0%B2%D1%80%D0%B5%D0%BC%D1%8F%20%D0%B2%D1%8B%D1%8F%D0%B2%D0%B8%D1%82%D1%8C%20%D1%80%D0%B0%D0%BA%20%D0%BA%D0%B8%D1%88%D0%B5%D1%87%D0%BD%D0%B8%D0%BA%D0%B0%20%D1%83%20%D0%B6%D0%B8%D1%82%D0%B5%D0%BB%D1%8F%20%D0%9F%D0%BE%D0%B4%D0%BC%D0%BE%D1%81%D0%BA%D0%BE%D0%B2%D1%8C%D1%8F%27):format(jpg)/YXJ0aWNsZXMvaW1hZ2UvMjAyNi8xMC9pbWctMjA3M19xU2dlaVd0LmpwZw.jpg)
Онкология
Анализ на скрытую кровь помог вовремя выявить рак кишечника у жителя Подмосковья
Анализ на скрытую кровь помог вовремя выявить рак кишечника у жителя Подмосковья 360.ru
Онкология
Colorectal cancer mortality falling, but ‘hotspots’ remain
Colorectal cancer mortality has declined sharply among adults aged 45 years and older across the U.S. since 2000, but some counties continue to have exceedingly high rates among certain racial and ethnic populations. These “hotspots” are most prevalent among Black men in the Southeast and American Indian or Alaska…
Онкология
Eddingpharm's GB268 Phase 2 Colorectal Cancer Trial Cleared by China's NMPA
Eddingpharm's GB268 Phase 2 Colorectal Cancer Trial Cleared by China's NMPA BigGo Finance
Онкология
Akeso Initiates Phase III Trial of Cadonilimab for Resectable MSI-H/dMMR Colon Cancer
Akeso Initiates Phase III Trial of Cadonilimab for Resectable MSI-H/dMMR Colon Cancer BioPharma APAC
Онкология
Akeso Initiates Phase III Trial of Cadonilimab for Resectable MSI-H/dMMR Colon Cancer
Akeso Initiates Phase III Trial of Cadonilimab for Resectable MSI-H/dMMR Colon Cancer BioPharma APAC
Онкология
Major Milestone in Colon Cancer: FDA Approves Atezolizumab Adjuvant Combination - Alliance for Clinical Trials in Oncology
Major Milestone in Colon Cancer: FDA Approves Atezolizumab Adjuvant Combination - Alliance for Clinical Trials in Oncology Oncodaily
Онкология
Tecentriq Plus Chemotherapy Wins Approval for Stage III dMMR Colon Cancer After Halving Recurrence or Death Risk
Tecentriq Plus Chemotherapy Wins Approval for Stage III dMMR Colon Cancer After Halving Recurrence or Death Risk Medical Daily
Онкология
In Britain, 32 patients had no bowel cancer recurrence for 33 months — ScienceDaily
In Britain, 32 patients had no bowel cancer recurrence for 33 months — ScienceDaily UA.NEWS
Онкология
Bowel cancer “melted away” after immunotherapy, then stayed away
Bowel cancer “melted away” after immunotherapy, then stayed away ScienceDaily
Онкология
Precision Medicine: From Promise to Practice in Colorectal Cancer Care – GCCA
Precision Medicine: From Promise to Practice in Colorectal Cancer Care – GCCA Oncodaily
Онкология
Рак кишечника: новый метод лечения вдвое снизил риск возвращения болезни
Рак кишечника: новый метод лечения вдвое снизил риск возвращения болезни Газета Балаково
Онкология
Phase III trial of cadonilimab begins in perioperative colon cancer
Phase III trial of cadonilimab begins in perioperative colon cancer The Clinical Trial Vanguard
Онкология
Aspirin Did Not Prevent Colorectal Cancer Return After Liver Metastasis Treatment
Aspirin Did Not Prevent Colorectal Cancer Return After Liver Metastasis Treatment Cure Today